Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax

Abstract The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax® ) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vacc...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 25; no. 10; pp. 1780 - 1788
Main Authors: Semenova, V.A, Schmidt, D.S, Taylor, T.H, Li, H, Steward-Clark, E, Soroka, S.D, Ballard, M.M, Quinn, C.P
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 26-02-2007
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax® ) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to ≥10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
AbstractList The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax ®) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to ≥10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to > or =10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to > or =10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax®) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to >=10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax super([registered])) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to >=10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
Abstract The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax® ) injections were determined in a cross-sectional study of sera from 63 vaccinees and 13 clinical anthrax patients. The data show that both vaccination with three AVA injections and clinical anthrax elicit anti-PA IgG1, IgG2, and IgG3 subclass responses. An anti-PA IgG4 response was detected in AVA recipients after the fourth injection. The anthrax lethal toxin (LTx) neutralization efficacy of sera from recipients who received 4 to ≥10 AVA injections did not vary significantly in relation to changes in distribution of anti-PA IgG1 and IgG4 subclasses.
Author Soroka, S.D
Steward-Clark, E
Quinn, C.P
Ballard, M.M
Li, H
Semenova, V.A
Schmidt, D.S
Taylor, T.H
Author_xml – sequence: 1
  fullname: Semenova, V.A
– sequence: 2
  fullname: Schmidt, D.S
– sequence: 3
  fullname: Taylor, T.H
– sequence: 4
  fullname: Li, H
– sequence: 5
  fullname: Steward-Clark, E
– sequence: 6
  fullname: Soroka, S.D
– sequence: 7
  fullname: Ballard, M.M
– sequence: 8
  fullname: Quinn, C.P
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18517851$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17229495$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v1DAQhi1URLeFnwCyhEBwyOJx4nxcQKsKSqVKHPhQb5bjTLpess5iO0v33_Sn4uwGrdRLD5ZlzTOvZ-adM3Jie4uEvAQ2Bwb5h9V8q7Q2FuecsXwOMGe8fEJmUBZpwgWUJ2TGeJ4lGbCbU3Lm_YoxJlKonpFTKDivskrMyP3Cqm7njad9S5UNJtm4PqAOZov79y1aenV7Sf1Q6055TxvjgzP1EExvqbHUoTYbgzb8l1g6dUen4qhqfO9qbOi7xa_F-xhu6EaFA_7XhCXVQ1AW-8HvY8YuVaf20pPSc_K0VZ3HF9N9Tn5--fzj4mty_e3y6mJxnWjBipC0rc5TBogs0yhQlxUTtVbjo1Zti6lCVHWVFmUBvGUtTxGLrBppDrXK0nPy9qAb-_8zoA9ybbzGrjtUJ_OyKkWViUdBqHIOWT6Crx-Aq35wcdyREVkBuWDAIiUOlHa99w5buXFmrdxOApOj03Ilp2HK0WkJIKPTMe_VpD7Ua2yOWZO1EXgzAcpr1bVOWW38kSsFFPFE7tOBwzjdrUEnvY7-aGxMtDbIpjePlvLxgYLujDXx09-4Q3_sWnoumfw-ruW4lSxnwFO4Sf8BtIvj3w
CODEN VACCDE
CitedBy_id crossref_primary_10_1128_IAI_00899_09
crossref_primary_10_1371_journal_pone_0230782
crossref_primary_10_1128_CVI_00696_15
crossref_primary_10_1016_j_jim_2011_12_002
crossref_primary_10_1016_j_jim_2008_01_007
crossref_primary_10_1086_596066
crossref_primary_10_1016_j_cell_2019_04_036
Cites_doi 10.3201/eid0810.020380
10.1016/j.vaccine.2003.07.004
10.1002/jmv.1890300203
10.1016/0165-2478(85)90082-3
10.1099/0022-1317-51-10-821
10.1016/0169-7439(93)80008-6
10.1007/BF00152686
10.1086/423937
10.1128/IAI.65.12.5171-5175.1997
10.1016/S1286-4579(99)80004-5
10.1089/hyb.1984.3.263
10.2105/AJPH.52.4.632
10.1128/JCM.32.10.2441-2447.1994
10.1016/j.femsim.2004.05.011
10.1099/00221287-147-6-1677
10.1128/IAI.52.2.356-363.1986
10.1006/prep.2000.1208
10.1128/JCM.27.7.1567-1571.1989
10.1016/S0264-410X(99)00394-1
10.1046/j.1365-2672.1999.00899.x
10.1128/CDLI.11.5.919-923.2004
10.1016/S0264-410X(97)00268-5
10.1203/00006450-199506000-00023
ContentType Journal Article
Copyright Elsevier Ltd
2006 Elsevier Ltd
2007 INIST-CNRS
Copyright Elsevier Limited Feb 26, 2007
Copyright_xml – notice: Elsevier Ltd
– notice: 2006 Elsevier Ltd
– notice: 2007 INIST-CNRS
– notice: Copyright Elsevier Limited Feb 26, 2007
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
Q9U
7X8
DOI 10.1016/j.vaccine.2006.11.028
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
ProQuest Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Family Health Database (Proquest)
Health & Medical Collection (Alumni Edition)
Health Management Database (Proquest)
PML(ProQuest Medical Library)
ProQuest Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Research Library Prep
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 1788
ExternalDocumentID 3379241041
10_1016_j_vaccine_2006_11_028
17229495
18517851
S0264410X0601231X
1_s2_0_S0264410X0601231X
Genre Journal Article
Comparative Study
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
0SF
123
1B1
1P~
1RT
1~.
1~5
29Q
3V.
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACPRK
ACRLP
ADBBV
ADEZE
ADFRT
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AEXOQ
AFCTW
AFJKZ
AFKRA
AFKWA
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGGSO
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
PSQYO
Q38
R2-
RIG
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
EFLBG
HMCUK
LCYCR
QYZTP
UKHRP
ABPIF
ABPTK
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T2
7T5
7U9
7XB
8FK
C1K
H94
K9.
M7N
MBDVC
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c507t-ffc6301ee04ce5ec8905bca4ce5baffe3aeeab9378712f0f23ee74904ce21ba43
ISSN 0264-410X
IngestDate Fri Oct 25 09:16:42 EDT 2024
Fri Oct 25 08:37:46 EDT 2024
Fri Nov 08 06:52:52 EST 2024
Thu Nov 21 23:07:52 EST 2024
Sat Sep 28 07:57:35 EDT 2024
Sun Oct 22 16:06:49 EDT 2023
Fri Feb 23 02:32:28 EST 2024
Tue Oct 15 22:55:51 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Bacillus anthracis
Anti-PA antibody
BioThrax
AVA
Anthrax
IgG subclasses
Human
Antibody
IgG
Recipient
Vaccine
Bacillaceae
Inhalation
Infection
Antigen
Bacillales
Bacteriosis
Bacteria
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c507t-ffc6301ee04ce5ec8905bca4ce5baffe3aeeab9378712f0f23ee74904ce21ba43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 17229495
PQID 1547165010
PQPubID 105530
PageCount 9
ParticipantIDs proquest_miscellaneous_68985945
proquest_miscellaneous_19621465
proquest_journals_1547165010
crossref_primary_10_1016_j_vaccine_2006_11_028
pubmed_primary_17229495
pascalfrancis_primary_18517851
elsevier_sciencedirect_doi_10_1016_j_vaccine_2006_11_028
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X0601231X
PublicationCentury 2000
PublicationDate 2007-02-26
PublicationDateYYYYMMDD 2007-02-26
PublicationDate_xml – month: 02
  year: 2007
  text: 2007-02-26
  day: 26
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: Netherlands
– name: Kidlington
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2007
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References Plikaytis, Holder, Pais, Maslanka, Gheesling, Carlone (bib20) 1994; 2
Little, Ivins, Fellows, Friedlander (bib3) 1997; 65
Semenova, Steward-Clark, Stamey, Taylor, Schmidt, Martin (bib14) 2004; 11
Baillie, Fowler, Turnbull (bib9) 1999; 87
[accessed on September 25, 2004].
Linde, Sundquiist, Mathiesen, Wahren (bib26) 1988; 23
O’Connell, Belanger, Haaland (bib21) 1993; 20
Brachman, Gold, Plotkin, Fekety, Werrin, Ingraham (bib13) 1962; 52
Leppla (bib15) 1991; 19
Bradwell AR. IgG and IgA subclasses in disease. The Binding Site, 1995. p. 29.
Welkos, Little, Friedlander, Fritz, Fellows (bib32) 2001; 147
McBride, Mogg, Telfer, Lever, Miller, Turnbull (bib10) 1998; 16
Hamilton (bib12) 1998
Jefferis (bib11) 1990
Little, Ivins, Fellows, Pitt, Norris, Andrews (bib5) 2004; 22
Ivins, Welkos (bib2) 1988; 4
Taylor T, Quinn C, Schmidt D, Freeman A, Li H, Semenova V, Hoekstra R, Plikaytis B. Novel mathematical approach to TNA endpoints. Abstracts of the 5th International Meeting on Anthrax, Nice, France, March 31–April 4, 2003.
[accessed on October 20, 2006].
Reimer, Phillips, Aloisio, Moore, Galland, Wells (bib17) 1984; 3
Scott, Briles, Nahm (bib24) 1990
Turnbull, Broster, Carman, Manchee, Melling (bib6) 1986; 52
Jefferis, Reimer, Skvaril, deLange, Ling, Lowe (bib18) 1985; 10
Quinn, Dull, Semenova, Li, Crotty, Taylor (bib8) 2004; 190
Hocart, Mackenzie, Steward (bib31) 1990; 30
Downloaded from
Sanders, Rijkers, Tenbergen-Meekers, Voorhorst-Ogink, Zegers (bib27) 1995; 37
Park, Leppla (bib16) 2000; 18
Quinn, Semenova, Elie, Romero-Steiner, Greene, Li (bib7) 2002; 8
Zackrisson, Lagergard, Trollfors (bib30) 1989; 27
Devey (bib34) 1990
Welkos, Friedlander, Weeks, Little, Mendelson (bib33) 2002; 51
Hammarstrom, Smith (bib25) 1986; 19
Gregorek, Madaliński, Woynarowski, Mikołajewicz, Syczewska, Socha (bib28) 2000; 18
Isa, Martinez, Giordano, Passeggi, de Wolf, Nates (bib29) 2002; 9
Little, Ivins (bib4) 1999; 1
Baillie, Townend, Walker, Eriksson, Williamson (bib22) 2004; 42
Semenova (10.1016/j.vaccine.2006.11.028_bib14) 2004; 11
Leppla (10.1016/j.vaccine.2006.11.028_bib15) 1991; 19
Turnbull (10.1016/j.vaccine.2006.11.028_bib6) 1986; 52
Hocart (10.1016/j.vaccine.2006.11.028_bib31) 1990; 30
Little (10.1016/j.vaccine.2006.11.028_bib4) 1999; 1
Isa (10.1016/j.vaccine.2006.11.028_bib29) 2002; 9
Zackrisson (10.1016/j.vaccine.2006.11.028_bib30) 1989; 27
Quinn (10.1016/j.vaccine.2006.11.028_bib7) 2002; 8
Sanders (10.1016/j.vaccine.2006.11.028_bib27) 1995; 37
10.1016/j.vaccine.2006.11.028_bib19
Hamilton (10.1016/j.vaccine.2006.11.028_bib12) 1998
Reimer (10.1016/j.vaccine.2006.11.028_bib17) 1984; 3
Baillie (10.1016/j.vaccine.2006.11.028_bib9) 1999; 87
Devey (10.1016/j.vaccine.2006.11.028_bib34) 1990
10.1016/j.vaccine.2006.11.028_bib35
Quinn (10.1016/j.vaccine.2006.11.028_bib8) 2004; 190
Baillie (10.1016/j.vaccine.2006.11.028_bib22) 2004; 42
Little (10.1016/j.vaccine.2006.11.028_bib5) 2004; 22
O’Connell (10.1016/j.vaccine.2006.11.028_bib21) 1993; 20
Welkos (10.1016/j.vaccine.2006.11.028_bib33) 2002; 51
Little (10.1016/j.vaccine.2006.11.028_bib3) 1997; 65
Linde (10.1016/j.vaccine.2006.11.028_bib26) 1988; 23
10.1016/j.vaccine.2006.11.028_bib1
Ivins (10.1016/j.vaccine.2006.11.028_bib2) 1988; 4
Jefferis (10.1016/j.vaccine.2006.11.028_bib18) 1985; 10
Plikaytis (10.1016/j.vaccine.2006.11.028_bib20) 1994; 2
Hammarstrom (10.1016/j.vaccine.2006.11.028_bib25) 1986; 19
Brachman (10.1016/j.vaccine.2006.11.028_bib13) 1962; 52
Welkos (10.1016/j.vaccine.2006.11.028_bib32) 2001; 147
Jefferis (10.1016/j.vaccine.2006.11.028_bib11) 1990
McBride (10.1016/j.vaccine.2006.11.028_bib10) 1998; 16
Scott (10.1016/j.vaccine.2006.11.028_bib24) 1990
Park (10.1016/j.vaccine.2006.11.028_bib16) 2000; 18
10.1016/j.vaccine.2006.11.028_bib23
Gregorek (10.1016/j.vaccine.2006.11.028_bib28) 2000; 18
References_xml – volume: 52
  start-page: 356
  year: 1986
  end-page: 363
  ident: bib6
  article-title: Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity
  publication-title: Infect Immun
  contributor:
    fullname: Melling
– volume: 147
  start-page: 1677
  year: 2001
  end-page: 1685
  ident: bib32
  article-title: The role of antibodies to
  publication-title: Microbiology
  contributor:
    fullname: Fellows
– volume: 22
  start-page: 422
  year: 2004
  end-page: 430
  ident: bib5
  article-title: Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
  publication-title: Vaccine
  contributor:
    fullname: Andrews
– volume: 190
  start-page: 1228
  year: 2004
  end-page: 1236
  ident: bib8
  article-title: Immune responses to
  publication-title: J Infect Dis
  contributor:
    fullname: Taylor
– volume: 23
  start-page: 27
  year: 1988
  end-page: 32
  ident: bib26
  article-title: IgG susclasses to subviral components
  publication-title: Monogr Allerg
  contributor:
    fullname: Wahren
– volume: 37
  start-page: 812
  year: 1995
  end-page: 819
  ident: bib27
  article-title: Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infection
  publication-title: Pediatr Res
  contributor:
    fullname: Zegers
– volume: 16
  start-page: 810
  year: 1998
  end-page: 817
  ident: bib10
  article-title: Protective efficacy of a recombinant protective antigen against
  publication-title: Vaccine
  contributor:
    fullname: Turnbull
– volume: 52
  start-page: 632
  year: 1962
  end-page: 645
  ident: bib13
  article-title: Field evaluation of a human anthrax vaccine
  publication-title: Am J Public Health
  contributor:
    fullname: Ingraham
– volume: 42
  start-page: 267
  year: 2004
  end-page: 270
  ident: bib22
  article-title: Characterization of the human immune response to the UK anthrax vaccine
  publication-title: FEMS Immun Med Microbiol
  contributor:
    fullname: Williamson
– volume: 11
  start-page: 919
  year: 2004
  end-page: 923
  ident: bib14
  article-title: Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: Martin
– volume: 18
  start-page: 293
  year: 2000
  end-page: 302
  ident: bib16
  article-title: Optimized production and purification of
  publication-title: Protein Exp Purif
  contributor:
    fullname: Leppla
– volume: 51
  start-page: 821
  year: 2002
  ident: bib33
  article-title: In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody
  publication-title: J Med Microbiol
  contributor:
    fullname: Mendelson
– volume: 18
  start-page: 1210
  year: 2000
  end-page: 1217
  ident: bib28
  article-title: The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection
  publication-title: Vaccine
  contributor:
    fullname: Socha
– volume: 87
  start-page: 306
  year: 1999
  end-page: 308
  ident: bib9
  article-title: Human immune responses to the UK human anthrax vaccine
  publication-title: J Appl Microbiol
  contributor:
    fullname: Turnbull
– volume: 19
  start-page: 122
  year: 1986
  end-page: 133
  ident: bib25
  article-title: IgG subclasses changes in bacterial infections
  publication-title: Monogr Allerg
  contributor:
    fullname: Smith
– year: 1998
  ident: bib12
  article-title: The human IgG subclasses
  publication-title: Calbiochem
  contributor:
    fullname: Hamilton
– volume: 4
  start-page: 12
  year: 1988
  end-page: 19
  ident: bib2
  article-title: Recent advances in the development of an improved, human anthrax vaccine
  publication-title: Eur J Epidemiol
  contributor:
    fullname: Welkos
– volume: 27
  start-page: 1567
  year: 1989
  end-page: 1571
  ident: bib30
  article-title: Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine
  publication-title: Clin Microb
  contributor:
    fullname: Trollfors
– start-page: 161
  year: 1990
  end-page: 183
  ident: bib24
  article-title: Selective IgG subclass expression: biologic, clinical and functional aspects
  publication-title: The human IgG subclasses: molecular analysis of structure, function and regulation
  contributor:
    fullname: Nahm
– volume: 30
  start-page: 92
  year: 1990
  end-page: 96
  ident: bib31
  article-title: Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A
  publication-title: Med Virol
  contributor:
    fullname: Steward
– volume: 10
  start-page: 223
  year: 1985
  end-page: 230
  ident: bib18
  article-title: Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study
  publication-title: Immunol Lett
  contributor:
    fullname: Lowe
– volume: 8
  start-page: 1103
  year: 2002
  end-page: 1110
  ident: bib7
  article-title: Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human Immunoglobulin G antibodies to anthrax protective antigen
  publication-title: Emerg Infect Dis
  contributor:
    fullname: Li
– start-page: 93
  year: 1990
  end-page: 108
  ident: bib11
  article-title: Structure-function relationships of IgG subclasses
  publication-title: The human IgG subclasses: molecular analysis of structure, function and regulation
  contributor:
    fullname: Jefferis
– volume: 9
  start-page: 693
  year: 2002
  end-page: 697
  ident: bib29
  article-title: Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: Nates
– volume: 19
  start-page: 153
  year: 1991
  end-page: 158
  ident: bib15
  article-title: Purification and characterization of adenylyl cyclase from
  publication-title: Methods in immunology
  contributor:
    fullname: Leppla
– volume: 65
  start-page: 5171
  year: 1997
  end-page: 5175
  ident: bib3
  article-title: Passive protection by polyclonal antibodies against
  publication-title: Infect Immun
  contributor:
    fullname: Friedlander
– volume: 2
  start-page: 2441
  year: 1994
  end-page: 2447
  ident: bib20
  article-title: Determination of parallelism and nonparallelism in bioassay dilution curves
  publication-title: J Clin Microbiol
  contributor:
    fullname: Carlone
– volume: 1
  start-page: 131
  year: 1999
  end-page: 139
  ident: bib4
  article-title: Molecular pathogenesis of
  publication-title: Microbes Infect
  contributor:
    fullname: Ivins
– volume: 20
  start-page: 97
  year: 1993
  end-page: 114
  ident: bib21
  article-title: Calibration and assay development using the four-parameter logistic model
  publication-title: Chemometr Intell Lab Syst
  contributor:
    fullname: Haaland
– volume: 3
  start-page: 263
  year: 1984
  end-page: 273
  ident: bib17
  article-title: Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes
  publication-title: Hybridoma
  contributor:
    fullname: Wells
– start-page: 185
  year: 1990
  end-page: 194
  ident: bib34
  article-title: Affinity of IgG subclass antibodies
  publication-title: The human IgG subclasses: molecular analysis of structure, function and regulation
  contributor:
    fullname: Devey
– volume: 23
  start-page: 27
  year: 1988
  ident: 10.1016/j.vaccine.2006.11.028_bib26
  article-title: IgG susclasses to subviral components
  publication-title: Monogr Allerg
  contributor:
    fullname: Linde
– ident: 10.1016/j.vaccine.2006.11.028_bib1
– volume: 8
  start-page: 1103
  issue: 10
  year: 2002
  ident: 10.1016/j.vaccine.2006.11.028_bib7
  article-title: Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human Immunoglobulin G antibodies to anthrax protective antigen
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid0810.020380
  contributor:
    fullname: Quinn
– volume: 22
  start-page: 422
  issue: 3/4
  year: 2004
  ident: 10.1016/j.vaccine.2006.11.028_bib5
  article-title: Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2003.07.004
  contributor:
    fullname: Little
– volume: 19
  start-page: 153
  year: 1991
  ident: 10.1016/j.vaccine.2006.11.028_bib15
  article-title: Purification and characterization of adenylyl cyclase from Bacillus anthracis
  contributor:
    fullname: Leppla
– start-page: 185
  year: 1990
  ident: 10.1016/j.vaccine.2006.11.028_bib34
  article-title: Affinity of IgG subclass antibodies
  contributor:
    fullname: Devey
– volume: 30
  start-page: 92
  issue: 2
  year: 1990
  ident: 10.1016/j.vaccine.2006.11.028_bib31
  article-title: Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A
  publication-title: Med Virol
  doi: 10.1002/jmv.1890300203
  contributor:
    fullname: Hocart
– volume: 10
  start-page: 223
  issue: 3/4
  year: 1985
  ident: 10.1016/j.vaccine.2006.11.028_bib18
  article-title: Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study
  publication-title: Immunol Lett
  doi: 10.1016/0165-2478(85)90082-3
  contributor:
    fullname: Jefferis
– ident: 10.1016/j.vaccine.2006.11.028_bib35
– volume: 51
  start-page: 821
  issue: 10
  year: 2002
  ident: 10.1016/j.vaccine.2006.11.028_bib33
  article-title: In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody
  publication-title: J Med Microbiol
  doi: 10.1099/0022-1317-51-10-821
  contributor:
    fullname: Welkos
– volume: 20
  start-page: 97
  issue: 2
  year: 1993
  ident: 10.1016/j.vaccine.2006.11.028_bib21
  article-title: Calibration and assay development using the four-parameter logistic model
  publication-title: Chemometr Intell Lab Syst
  doi: 10.1016/0169-7439(93)80008-6
  contributor:
    fullname: O’Connell
– volume: 4
  start-page: 12
  issue: 1
  year: 1988
  ident: 10.1016/j.vaccine.2006.11.028_bib2
  article-title: Recent advances in the development of an improved, human anthrax vaccine
  publication-title: Eur J Epidemiol
  doi: 10.1007/BF00152686
  contributor:
    fullname: Ivins
– volume: 190
  start-page: 1228
  issue: 1
  year: 2004
  ident: 10.1016/j.vaccine.2006.11.028_bib8
  article-title: Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax
  publication-title: J Infect Dis
  doi: 10.1086/423937
  contributor:
    fullname: Quinn
– start-page: 161
  year: 1990
  ident: 10.1016/j.vaccine.2006.11.028_bib24
  article-title: Selective IgG subclass expression: biologic, clinical and functional aspects
  contributor:
    fullname: Scott
– volume: 65
  start-page: 5171
  issue: 12
  year: 1997
  ident: 10.1016/j.vaccine.2006.11.028_bib3
  article-title: Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs
  publication-title: Infect Immun
  doi: 10.1128/IAI.65.12.5171-5175.1997
  contributor:
    fullname: Little
– ident: 10.1016/j.vaccine.2006.11.028_bib23
– year: 1998
  ident: 10.1016/j.vaccine.2006.11.028_bib12
  article-title: The human IgG subclasses
  publication-title: Calbiochem
  contributor:
    fullname: Hamilton
– volume: 19
  start-page: 122
  year: 1986
  ident: 10.1016/j.vaccine.2006.11.028_bib25
  article-title: IgG subclasses changes in bacterial infections
  publication-title: Monogr Allerg
  contributor:
    fullname: Hammarstrom
– volume: 1
  start-page: 131
  issue: 2
  year: 1999
  ident: 10.1016/j.vaccine.2006.11.028_bib4
  article-title: Molecular pathogenesis of Bacillus anthracis infection
  publication-title: Microbes Infect
  doi: 10.1016/S1286-4579(99)80004-5
  contributor:
    fullname: Little
– volume: 3
  start-page: 263
  issue: 3
  year: 1984
  ident: 10.1016/j.vaccine.2006.11.028_bib17
  article-title: Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes
  publication-title: Hybridoma
  doi: 10.1089/hyb.1984.3.263
  contributor:
    fullname: Reimer
– ident: 10.1016/j.vaccine.2006.11.028_bib19
– start-page: 93
  year: 1990
  ident: 10.1016/j.vaccine.2006.11.028_bib11
  article-title: Structure-function relationships of IgG subclasses
  contributor:
    fullname: Jefferis
– volume: 52
  start-page: 632
  issue: 4
  year: 1962
  ident: 10.1016/j.vaccine.2006.11.028_bib13
  article-title: Field evaluation of a human anthrax vaccine
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.52.4.632
  contributor:
    fullname: Brachman
– volume: 2
  start-page: 2441
  issue: 10
  year: 1994
  ident: 10.1016/j.vaccine.2006.11.028_bib20
  article-title: Determination of parallelism and nonparallelism in bioassay dilution curves
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.32.10.2441-2447.1994
  contributor:
    fullname: Plikaytis
– volume: 42
  start-page: 267
  issue: 2
  year: 2004
  ident: 10.1016/j.vaccine.2006.11.028_bib22
  article-title: Characterization of the human immune response to the UK anthrax vaccine
  publication-title: FEMS Immun Med Microbiol
  doi: 10.1016/j.femsim.2004.05.011
  contributor:
    fullname: Baillie
– volume: 147
  start-page: 1677
  issue: Pt 6
  year: 2001
  ident: 10.1016/j.vaccine.2006.11.028_bib32
  article-title: The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores
  publication-title: Microbiology
  doi: 10.1099/00221287-147-6-1677
  contributor:
    fullname: Welkos
– volume: 52
  start-page: 356
  issue: 2
  year: 1986
  ident: 10.1016/j.vaccine.2006.11.028_bib6
  article-title: Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity
  publication-title: Infect Immun
  doi: 10.1128/IAI.52.2.356-363.1986
  contributor:
    fullname: Turnbull
– volume: 18
  start-page: 293
  issue: 3
  year: 2000
  ident: 10.1016/j.vaccine.2006.11.028_bib16
  article-title: Optimized production and purification of Bacillus anthracis lethal factor
  publication-title: Protein Exp Purif
  doi: 10.1006/prep.2000.1208
  contributor:
    fullname: Park
– volume: 9
  start-page: 693
  issue: 3
  year: 2002
  ident: 10.1016/j.vaccine.2006.11.028_bib29
  article-title: Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: Isa
– volume: 27
  start-page: 1567
  issue: 7
  year: 1989
  ident: 10.1016/j.vaccine.2006.11.028_bib30
  article-title: Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine
  publication-title: Clin Microb
  doi: 10.1128/JCM.27.7.1567-1571.1989
  contributor:
    fullname: Zackrisson
– volume: 18
  start-page: 1210
  issue: 13
  year: 2000
  ident: 10.1016/j.vaccine.2006.11.028_bib28
  article-title: The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(99)00394-1
  contributor:
    fullname: Gregorek
– volume: 87
  start-page: 306
  issue: 2
  year: 1999
  ident: 10.1016/j.vaccine.2006.11.028_bib9
  article-title: Human immune responses to the UK human anthrax vaccine
  publication-title: J Appl Microbiol
  doi: 10.1046/j.1365-2672.1999.00899.x
  contributor:
    fullname: Baillie
– volume: 11
  start-page: 919
  issue: 5
  year: 2004
  ident: 10.1016/j.vaccine.2006.11.028_bib14
  article-title: Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum
  publication-title: Clin Diagn Lab Immunol
  doi: 10.1128/CDLI.11.5.919-923.2004
  contributor:
    fullname: Semenova
– volume: 16
  start-page: 810
  issue: 8
  year: 1998
  ident: 10.1016/j.vaccine.2006.11.028_bib10
  article-title: Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(97)00268-5
  contributor:
    fullname: McBride
– volume: 37
  start-page: 812
  issue: 6
  year: 1995
  ident: 10.1016/j.vaccine.2006.11.028_bib27
  article-title: Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infection
  publication-title: Pediatr Res
  doi: 10.1203/00006450-199506000-00023
  contributor:
    fullname: Sanders
SSID ssj0005319
Score 1.9162236
Snippet Abstract The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax® )...
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax ®) injections...
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax) injections...
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax®) injections...
The anti-PA IgG1, IgG2, IgG3, and IgG4 subclass responses to clinical anthrax and to different numbers of anthrax vaccine adsorbed (AVA, BioThrax...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 1780
SubjectTerms Adult
Aged
Allergy and Immunology
Anthrax
Anthrax - immunology
Anthrax Vaccines - immunology
Anti-PA antibody
Antibodies, Bacterial - blood
Antibodies, Bacterial - classification
Antigens
Antigens, Bacterial - immunology
Antitoxins - blood
Applied microbiology
AVA
Bacillus anthracis
Bacterial Toxins - immunology
Biological & chemical terrorism
Biological and medical sciences
BioThrax
Blood banks
Dilution
Enzymes
Female
Fundamental and applied biological sciences. Psychology
Humans
IgG subclasses
Immune system
Immunoglobulin G - blood
Immunoglobulin G - classification
Infections
Inhalation
Injections
Male
Microbiology
Middle Aged
Neutralization
Toxins
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Title Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X0601231X
https://dx.doi.org/10.1016/j.vaccine.2006.11.028
https://www.ncbi.nlm.nih.gov/pubmed/17229495
https://www.proquest.com/docview/1547165010
https://search.proquest.com/docview/19621465
https://search.proquest.com/docview/68985945
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6IRASQlBuhTH8gCZQl5C7k8eKFYoEaGKlqvZiOa7DOom2WtaJ_Rt-Kse3uIVVXCQqtWqc2LmcLz6f7XNB6DkvwmhShBUMUznzkpLEXlnx0mNE8CwtGClK6Y08OCIfx_lBP-m3WjbAoyv7r5KGMpC19Jz9C2k3jUIB_AeZwy9IHX7_SO6rUUbgqU09E4lBWgjJbajYffflbbdellwyZ7lE02S90t4tfLqYCmMew2QiBfate8G4XILvskk9PyuFmnrojXpyUkGFGtDhWY2vHF8C5RTSuFbHdjph2uLOtrbKiEe64WamR4Uvv1CUduT3fLdQdPJ1OlEa48A_aordhMPQHzSl73Uqbn9tSoMoF_HMzbNZXxtn2FSrELGJl4TBWGsu3V3ngC1gaPlqf64dqS1ug5XeOSQ6a5TR9LCZX6lF9ITGqW8erV6ykrFejR_7eoDuo0CRymAsQ9sAXR5voWsRdHuy1z1OPzmDo1ilmWnuw_mTvbryVJuY0q0Fq-H9rXTilc0jI8WQhnfQbTO0wT2NybuoJWZtdF0nO71soxsfjBlHG-0d6oDpl_t46Pz_6n28hw9dKHWo0x5Jay3lMo5t9Xvou8U4nlf4J4xjg3EMGMcW43gV43g6ww7jpgmJSmyeDrYYxy8A4S9h9wRbfGOJb9zgW-1z-LYt3Uef3_SHrweeyTTicRgPnXtVxTPQdEIECRep4HkRpCVncqNkVSViJgQrgcnnJIyqoIpiIUhSyKOjsGRJ_ABtz-Yz8QjhUBQiD2Pg5ZFSjjljnGRBUcEnTcukg3wrVbrQAWWotbQ8peZGZXLYDAbnFGDQQcTKnlpvadDvojadTk1DWkc0oL_gsIPypqbh05onUwD67066u4Yyd6kwQiPw7aAdCzvqLiQFqgtDvjDooGfNbtBXchFSy4WCxo-AnaWbj8jyIk-LBI54qOHsTk6iqEiK9PG_39gTdNP1ODto-_xsKZ6irXqy3FVv6w8jGykH
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+anti-protective+antigen+IgG+subclass+distribution+in+recipients+of+anthrax+vaccine+adsorbed+%28AVA%29+and+patients+with+cutaneous+and+inhalation+anthrax&rft.jtitle=Vaccine&rft.au=Semenova%2C+V.A.&rft.au=Schmidt%2C+D.S.&rft.au=Taylor%2C+T.H.&rft.au=Li%2C+H.&rft.date=2007-02-26&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=25&rft.issue=10&rft.spage=1780&rft.epage=1788&rft_id=info:doi/10.1016%2Fj.vaccine.2006.11.028&rft.externalDocID=S0264410X0601231X
thumbnail_m http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X07X04067%2Fcov150h.gif